annb0t
Top 20
uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
CSL Limited (OTC:CSLLY) and uniQure Inc (NASDAQ:QURE)Â announced the four-year results from the pivotal HOPE-B study confirming the long-term durability and safety of a one-time infusion of Hemgenix (etranacogene dezaparvovec-drlb) for adults hemophilia B patients.
The data showed that through four years, Hemgenix continues to deliver elevated and sustained factor IX activity levels, can offer lo...
>>> Read more: uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
CSL Limited (OTC:CSLLY) and uniQure Inc (NASDAQ:QURE)Â announced the four-year results from the pivotal HOPE-B study confirming the long-term durability and safety of a one-time infusion of Hemgenix (etranacogene dezaparvovec-drlb) for adults hemophilia B patients.
The data showed that through four years, Hemgenix continues to deliver elevated and sustained factor IX activity levels, can offer lo...
>>> Read more: uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
